TCM Ltd
NSE: BSE: 524156
₹44.83
(4.26%)
Thu, 12 Mar 2026, 02:25 pm
Market Cap321.55M
PE Ratio0
Dividend0
Process Industries
Chemicals: Specialty
24.5KTCM Analysis
dividend
- Unable to evaluate TCM's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate TCM's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- TCM had negative shareholder equity 5 years ago, it is now positive therefore their debt level has improved.
- TCM's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- TCM has less than a year of cash runway if free cash flow continues to grow at historical rates of 22.7% each year.
- TCM has less than a year of cash runway based on current free cash flow.
- Operating cash flow is negative therefore debt is not well covered.
- Debt is not covered by short term assets, assets are 0.1x debt.
- TCM's long term commitments exceed its cash and other short term assets.
- TCM's level of debt (77.7%) compared to net worth is high (greater than 40%).
- High level of physical assets or inventory.
management
- The average tenure for the TCM board of directors is over 10 years, this suggests they are a seasoned and experienced board.
- The average tenure for the TCM management team is less than 2 years, this suggests a new team.
misc
- TCM is not covered by any analysts.
past
- Unable to compare TCM's 1-year earnings growth to the 5-year average as it is not currently profitable.
- TCM does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
- It is difficult to establish if TCM has efficiently used its assets last year compared to the IN Chemicals industry average (Return on Assets) as it is loss-making.
- It is difficult to establish if TCM improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
- It is difficult to establish if TCM has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
- Unable to compare TCM's 1-year growth to the IN Chemicals industry average as it is not currently profitable.
value
- TCM is good value based on assets compared to the IN Chemicals industry average.
- TCM is loss making, we can't compare its value to the IN Chemicals industry average.
- TCM is loss making, we can't compare the value of its earnings to the India market.
- BSE:524156 is down -9.2% underperforming the Chemicals industry which returned 6.9% over the past month.
- BSE:524156 is down -9.2% underperforming the market in India which returned 8% over the past month.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800